Age-Based Outcomes in Patients With mRCC Treated With First-Line Targeted Therapy or Checkpoint Immunotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: